Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish RegistryAdrían Alegre, J Díaz-Mediavilla, Jesús F. San Miguel et al.|Bone Marrow Transplantation|1998Cited by 85
Evaluation of minimal residual disease in multiple myeloma patients by fluorescent‐polymerase chain reaction: the prognostic impact of achieving molecular responsePilar Martínez‐Sánchez, Joaquín Martínez‐López, Rafael Martínez et al.|British Journal of Haematology|2008Cited by 58
Myeloablative Treatments for Multiple Myeloma: Update of a Comparative Study of Different Regimens Used in Patients from the Spanish Registry for Transplantation in Multiple MyelomaJuan José Lahuerta, Jesús F. San Miguel, Carlos Grande et al.|Leukemia & lymphoma/Leukemia and lymphoma|2002Cited by 54
A Phase I/II National, Multi-Center, Open-Label Study of Bortezomib Plus Melphalan and Prednisone (V-MP) in Elderly Untreated Multiple Myeloma Patients.MV Mateos, Jesús F. San Miguel, Joan Bladé et al.|Blood|2004Cited by 39